-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...

-The Indian Express Farmers in worst-hit Beed had hoped that a good harvest this year would help them repay loans. Beed (Maharashtra): Radhabai, a 30-year-old daily wager from Ekdara village of Beed district, was plucking cotton on March 8 when the overcast sky opened up. Heavy rain with tennis ball-sized hailstones forced her to take shelter under a tree. "Heavy wind dislodged a branch of the tree that fell on her head....

-Down to Earth Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports Indicating failure of the National Pharmaceutical Pricing Policy (NPPP), 2012 and the Drugs Price Control Order (DPCO), 2013, two recently-released reports have stated that medicines are still not accessible and affordable for the citizens of the country. The reports that were jointly released...

-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...

-The Business Standard But beef up safeguards for genetically modified crop trials Environment Minister M Veerappa Moily has made the right move by overturning the untenable position taken by his predecessors on field trials of genetically modified (GM) crops. Around 200 gene-altered varieties of different crops will now be allowed to be field-tested, subject, of course, to certain necessary conditions. This could, depending on the outcome of the trials, clear the way...